4-氰-4-苯基环己酮 | 25115-74-6

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪酮(含烯醇)
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氰-4-苯基环己酮
• 中文别名: 4-氰基-4-苯基环己酮
• 英文名称: 4-cyano-4-phenylcyclohexanone
• 英文别名: 4-oxo-1-phenylcyclohexanecarbonitrile；4-oxo-1-phenylcyclohexane-1-carbonitrile；4-phenyl-4-cyanocyclohexanone；4-oxo-1-phenyl-1-cyclohexanecarbonitrile
• CAS: 25115-74-6
• 化学式: C₁₃H₁₃NO
• mdl: MFCD00044816
• 分子量: 199.252
• InChiKey: GKXOABVSZWCJJK-UHFFFAOYSA-N

物化性质

• 熔点：
  114-119 °C
• 沸点：
  336.78°C (rough estimate)
• 密度：
  1.0671 (rough estimate)
• 稳定性/保质期：

  如果按照规格使用和储存，则不会分解。避免接触氧化物和酸。

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.384
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2926909090
• 危险品运输编号：
  UN3439
• 包装等级：
  III
• 危险类别：
  6.1
• 储存条件：
  将贮藏器密封，放入一个紧密的容器中，并存放在阴凉、干燥的地方。

SDS

Name:	4-Cyano-4-Phenylcyclohexanone 97% Material Safety Data Sheet
Synonym:	None
CAS:	25115-74-6

Section 1 - Chemical Product MSDS Name:4-Cyano-4-Phenylcyclohexanone 97% Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
25115-74-6	4-Cyano-4-Phenylcyclohexanone	97	246-631-7

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 25115-74-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 110.00 - 114.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H13NO
Molecular Weight: 199.25

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 25115-74-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Cyano-4-Phenylcyclohexanone - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 25115-74-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 25115-74-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 25115-74-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氰-4-苯基环己酮 在 三乙烯二胺 、 N-溴代丁二酰亚胺(NBS) 作用下， 以 四氯化碳 、 乙腈 为溶剂， 反应 1.67h， 生成 4-Oxo-1-phenyl-2-cyclohexen-1-carbonitril
  参考文献：
  名称：

  1,4-Pentadien-3-ones, 26. Mitt. s-trans / s-trans-fixed 1,4-pentadien-3-ones 的表示及其与亚甲基活性化合物的反应

  摘要：

  标题化合物3由1通过各种途径获得。只有部分反应类似 10 和 13。使用反应性亚甲基化合物，可以获得许多交叉共轭系统，21-24，其结构正在研究和讨论中。

  DOI：

  10.1002/ardp.19863191007
• 作为产物：
  描述：

  methyl 5-cyano-5-(4-chlorophenyl)-2-oxocyclohexanecarboxylate 在 硫酸 作用下， 以 正己烷 、 5-氰基-2-氧代-5-苯基环己烷羧酸甲酯 、 溶剂黄146 、 乙酸乙酯 为溶剂， 以75%的产率得到4-氰-4-苯基环己酮
  参考文献：
  名称：

  4-Amino-4-phenylcyclohexanone ketal compositions and process of use

  摘要：

  一类新的4-氨基-4-芳基环己酮，它们的缩醛和酸盐已经合成，并发现对于缓解动物的疼痛很有用。它们的镇痛活性似乎是很高的，并且一些还表现出对镇痛引起的心血管、呼吸和行为抑制有用的麻醉拮抗活性。其中几种显示出混合的镇痛和麻醉拮抗活性。该类化合物的首选化合物是4-(间羟基苯基)-4-二甲氨基环己酮乙二醚缩醛，以及4-(间羟基苯基)-4-(正丁基甲基氨基)环己酮乙二醚缩醛，作为游离碱和其盐酸盐形式。描述了合成和中间体的过程。披露了单位剂量形式和治疗方法。

  公开号：

  US04065573A1

文献信息

• SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
  申请人：NOLTE Bert

  公开号：US20090247530A1

  公开（公告）日：2009-10-01

  The invention relates to compounds that have an affinity to the μ-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.

  这项发明涉及具有与μ-阿片受体和ORL 1-受体亲和力的化合物，其生产方法，含有这些化合物的药物以及利用这些化合物治疗疼痛和其他疾病的用途。
• Pd-Catalyzed Carbonylation of Vinyl Triflates To Afford α,β-Unsaturated Aldehydes, Esters, and Amides under Mild Conditions
  作者：Shaoke Zhang、Helfried Neumann、Matthias Beller

  DOI：10.1021/acs.orglett.9b00765

  日期：2019.5.17

  An efficient and general protocol for the synthesis of α,β-unsaturated aldehydes, esters, and amides via carbonylation of vinyl triflates including derivatives of camphor, ketoisophorone, verbenone, and pulegone was developed. Crucial for these transformations is the use of a specific palladium catalyst containing a pyridyl-substituted dtbpx-type ligand. This procedure also allows for an easy access

  开发了一种有效的通用方案，可通过乙烯基三氟甲磺酸酯的羰基化反应合成α，β-不饱和醛，酯和酰胺，包括樟脑，酮异佛尔酮，马鞭草酮和普乐酮。这些转化的关键是使用含有吡啶基取代的d t bpx型配体的特定钯催化剂。该方法还使得容易从相应的酮获得二羰基化产物。
• [EN] TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX<br/>[FR] INHIBITEURS DE LA MYÉLOPEROXYDASE ET/OU DE L'EPX À BASE DE TRIAZOLOPYRIDINES
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2017161145A1

  公开（公告）日：2017-09-21

  The present invention provides compounds of Formula (I); wherein the substituents are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

  本发明提供了式(I)的化合物；其中取代基各自如说明书中所定义，以及包含任一此类新颖化合物的组合物。这些化合物是髓过氧化物酶（MPO）抑制剂和/或嗜酸性粒细胞过氧化物酶（EPX）抑制剂，并且可用于治疗和/或预防动脉粥样硬化、心力衰竭、慢性阻塞性肺病（COPD）及相关疾病。
• SUBSTITUTED HETEROARYL DERIVATIVES
  申请人：Zemolka Saskia

  公开号：US20100009986A1

  公开（公告）日：2010-01-14

  The invention relates to substituted heteroaryl derivatives, to methods for the production thereof, to medicaments containing said compounds and to the use of substituted heteroaryl derivatives for producing medicaments.

  这项发明涉及替代杂环芳基衍生物，涉及其生产方法，含有该化合物的药物以及利用替代杂环芳基衍生物生产药物的用途。
• [EN] ADAMANTYL PYRROLIDIN-2-ONE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS<br/>[FR] UTILISATION DE DERIVES D'ADAMANTYLE PYRROLIDIN-2-ONE COMME INHIBITEURS DE LA 11-BETA-HYDROXYSTEROIDE DESHYDROGENASE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005108361A1

  公开（公告）日：2005-11-17

  The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1 or 2; M represents a direct bond or a C1-3alkyl linker optionally substituted with one or two substituents selected from C1-4alkyl, C1-3alkyloxy-C1-4alkyl-, hydroxy-C1-4alkyl-, hydroxy, C1-3alkyloxy- or phenyl-C1-4alkyl-; R1 and R2 each independently represent hydrogen, halo, cyano, hydroxy, Cl-4alkyl optionally substituted with halo, C1-4alkyloxy- optionally substituted with one or where possible two or three substituents selected from hydroxy, Ar1 and halo ; R3 represents hydrogen, halo, C1-4alkyl, C1-4alkyloxy-, cyano or hydroxy; R4 represents hydrogen, halo, Cl-4alkyl, hydroxy, cyano or C1-4alkyloxy- optionally substituted with one or where possible two or three substituents selected from hydroxy and halo; R5 represents hydrogen, C1-4alkyl or Ar2-C1-4alkyl-; R6 represents hydrogen, hydroxy, halo, C1-4alkyl or C1-4alkyoxy-; R7 represents hydrogen or R7 and R5 taken together with the carbon atom to which they are attached from a -C2-alkyl- linker; Ar1 and Ar2 each independently represent phenyl or naphtyl wherein said phenyl and naphtyl are optionally substituted with C1-4alkyl, C1-4alkyloxy-, or phenyl-C1-4alkyl.

  N-氧化物形式，药学上可接受的加合盐及其立体化异构体形式，其中n为1或2；M代表直接键或C1-3烷基连接物，可选地取代为从C1-4烷基、C1-3烷氧基-C1-4烷基、羟基-C1-4烷基、羟基、C1-3烷氧基或苯基-C1-4烷基中选择的一个或两个取代基；R1和R2各自独立地代表氢、卤素、氰基、羟基、Cl-4烷基，可选地取代为卤素、C1-4烷氧基，可选地取代为从羟基、Ar1和卤素中选择的一个或多个取代基；R3代表氢、卤素、C1-4烷基、C1-4烷氧基、氰基或羟基；R4代表氢、卤素、Cl-4烷基、羟基、氰基或C1-4烷氧基，可选地取代为从羟基和卤素中选择的一个或多个取代基；R5代表氢、C1-4烷基或Ar2-C1-4烷基；R6代表氢、羟基、卤素、C1-4烷基或C1-4烷氧基；R7代表氢或R7和R5一起与它们连接的碳原子形成-C2-烷基连接物；Ar1和Ar2各自独立地代表苯或萘基，其中所述苯和萘基可选地取代为C1-4烷基、C1-4烷氧基或苯基-C1-4烷基。